Actinium Pharmaceuticals, Inc. (ATNM)
1.22
+0.03
(+2.52%)
USD |
NYAM |
Sep 18, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Total Liabilities (Quarterly) : 9.855M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.855M |
| March 31, 2026 | 43.13M |
| December 31, 2025 | 44.37M |
| September 30, 2025 | 42.37M |
| June 30, 2025 | 44.00M |
| March 31, 2025 | 42.95M |
| December 31, 2024 | 44.14M |
| September 30, 2024 | 43.91M |
| June 30, 2024 | 46.03M |
| March 31, 2024 | 44.50M |
| December 31, 2023 | 45.07M |
| September 30, 2023 | 45.36M |
| June 30, 2023 | 45.97M |
| March 31, 2023 | 44.82M |
| December 31, 2022 | 47.71M |
| September 30, 2022 | 45.56M |
| June 30, 2022 | 43.62M |
| March 31, 2022 | 5.725M |
| December 31, 2021 | 6.843M |
| September 30, 2021 | 4.194M |
| June 30, 2021 | 3.955M |
| March 31, 2021 | 4.361M |
| December 31, 2020 | 5.078M |
| September 30, 2020 | 5.10M |
| June 30, 2020 | 5.184M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.344M |
| December 31, 2019 | 6.026M |
| September 30, 2019 | 6.382M |
| June 30, 2019 | 6.118M |
| March 31, 2019 | 6.892M |
| December 31, 2018 | 6.077M |
| September 30, 2018 | 4.122M |
| June 30, 2018 | 5.266M |
| March 31, 2018 | 6.393M |
| December 31, 2017 | 4.666M |
| September 30, 2017 | 3.529M |
| June 30, 2017 | 4.106M |
| March 31, 2017 | 5.370M |
| December 31, 2016 | 4.521M |
| September 30, 2016 | 3.028M |
| June 30, 2016 | 2.488M |
| March 31, 2016 | 3.286M |
| December 31, 2015 | 4.614M |
| September 30, 2015 | 2.155M |
| June 30, 2015 | 3.051M |
| March 31, 2015 | 3.611M |
| December 31, 2014 | 9.492M |
| September 30, 2014 | 10.23M |
| June 30, 2014 | 11.12M |
| March 31, 2014 | 20.03M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.16M |
| Shareholders Equity (Quarterly) | 30.30M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 4.076 |
| Net Debt Paydown Yield | 0.06% |